market

Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery   Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service […]

Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the fragment-based approach is a versatile technique, enabling researchers to mitigate a number of existing challenges   London   Roots Analysis has announced the addition of the “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030” report to its

The success of CTLA4, PD-1, and PD-L1 inhibitors paved the way for researchers to explore the vast therapeutic potential of immune checkpoint modulation, enabling the discovery of product candidates against clinical conditions beyond oncology   Roots Analysis has announced the addition of “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030” report to its list